J Clin Invest 1993;91:3017.ArticlePubMedPMC 56
August 11th, 2025: Research Suggests Possible Muscle Weakness Risks from Ozempic A new study from the University of Utah Health raises concerns about potential muscle-related effects of GLP-1 drugs, noting reduced strength in certain muscles despite little change in muscle size
Study 9 (HAUSER-OLE, NCT02624869) was an open-label, single-arm, multicenter, 80-week study to evaluate the safety, tolerability, and efficacy of REPATHA for LDL-C reduction in pediatric patients aged 10 to 17 years with HoFH [see Use in Specific Populations (8.4)]
Neither platform negates the need for baseline evaluationrather, they differ in how thoroughly and quickly they complete it
Homemade stocks for thickening soups and making risottos creamy can also live in the frozen depths until you need them